Medical marijuana patients on Long Island will be able to buy whole cannabis flower for the first time Wednesday. 

Columbia Care’s dispensary in Riverhead is now offering the Sour Kush strain in whole flower form to patients registered with the New York State Department of Health’s Medical Marijuana Program. 

Publicly traded Columbia Care, which also has medical cannabis dispensaries in Brooklyn, Manhattan and Rochester, becomes the first licensed company to offer whole flower to New York’s medical cannabis community.  

Previously, medical marijuana dispensaries in the state could only sell ground flower, along with vaping oil, oral products and topical applications, but with the legislation passed this spring that allows legalized adult use of cannabis, whole flower was added to the list of approved medical offerings. 

Columbia Care dispensary in Riverhead. / Google Maps image

Columbia Care’s Riverhead dispensary at 1333 East Main St. is offering Sour Kush in whole flower priced at $50 for an eighth of an ounce. 

Last month, Columbia Care received state approval to start cultivation and processing operations at its new Riverhead facility. Earlier this year, the company acquired a 34-acre cultivation site on Sound Avenue from Van de Wetering Greenhouses for $42.5 million. 

Columbia Care expects its first harvest at the Riverhead facility before the end of the year. The company also plans to add four more medical dispensaries in the state, three of which will be co-located with adult-use, pending regulatory approval.  

“We are New York’s home team, so it shouldn’t come as a surprise that Columbia Care continues to be on the leading edge of the state’s cannabis program – from opening the first medical dispensary in New York State and New York City, to being the first to bring a critical, natural medicine in its most highly-demanded and cost-effective form, whole flower, to New Yorkers,” Nicholas Vita, CEO of Columbia Care, said in a company statement. “This is a meaningful moment to us, and we are grateful to our team for their dedication to the New York market as well as to the state’s leadership and the Office of Cannabis Management for moving this program forward. This is the next step in the evolution of New York’s legal cannabis market, and we are committed to leading its continued forward progress.” 

After months of delays, the state’s newly formed Cannabis Control Board finally met for the first time last month and is currently accepting public comment on regulations that will allow medical marijuana patients to grow up to six cannabis plants at their homes. It’s expected that retail sales of adult-use cannabis will begin sometime next year. 


(this story/news/article has not been edited by PostX News staff and is published from a syndicated feed)



Please enter your comment!
Please enter your name here